Globus Medical (GMED)

Executive Summary

Globus Medical is a leading musculoskeletal device company focused on innovative solutions for spine and orthopedic disorders. With a strong portfolio of procedurally integrated implants and enabling technologies such as the ExcelsiusGPS™ surgical robot and navigation system, the company has established a competitive edge in minimally invasive surgery. Following the transformative merger with NuVasive in 2023, Globus Medical now commands a comprehensive product offering spanning spine, orthopedics, and enabling technologies, positioning itself as the second-largest pure-play musculoskeletal company globally. The integration is expected to unlock significant operational synergies, expand market access, and accelerate innovation. Driven by an aging population, rising demand for outpatient spine procedures, and technological adoption in surgery, Globus Medical is poised for sustained revenue growth and margin expansion. The company's commitment to addressing unmet clinical needs and improving patient outcomes underpins its long-term value proposition.

Upcoming Catalysts (preview)

• 2026Completion of NuVasive integration and realization of cost synergies85% success
• 2026Next-generation ExcelsiusGPS robot system launch or expanded indications70% success
• Q3 2026Potential FDA approval for novel orthopedic implant or enabling technology60% success